tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nicole Germino, 38 are a BUY (95%), 2 are a HOLD (5%).
Analyst Nicole Germino, currently employed at TRUIST, carries an average stock price target met ratio of 55.29% that have a potential upside of 58.54% achieved within 194 days.
Nicole Germino’s has documented 75 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 31-Oct-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/16/2024. The price target of $48 was fulfilled within 12 days with a profit of $22.9 (91.24%) receiving and performance score of 76.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Oct-2019
$45
$21.47 (91.25%)
$45
1 months 14 days ago
(01-Sep-2026)
6/10 (60%)
$9.82 (27.91%)
410
Buy Since 18-Aug-2025
$50
$26.47 (112.49%)
$50
1 months 27 days ago
(18-Aug-2026)
3/9 (33.33%)
$17.87 (55.62%)
477
Buy Since 25-Mar-2025
$43
$16.26 (60.81%)
$43
4 months 17 days ago
(28-May-2026)
1/4 (25%)
$15.27 (55.07%)
220
Buy Since 10-Dec-2025
$62
$35.26 (131.86%)
$35
10 months 5 days ago
(10-Dec-2025)
1/2 (50%)
$26.13 (72.85%)
418
Hold Since 24-Mar-2023
1 years 6 months 21 days ago
(24-Mar-2025)
0/1 (0%)
$-9.98 (-79.97%)
What Year was the first public recommendation made by Nicole Germino?
